• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Drug Nomenclature Monographs

Drug Nomenclature Monographs

Monograph Number

 
Drug ClassificationC-DRG-00101
Dosage FormC-DRG-00201
Route of AdministrationC-DRG-00301
Ingredient NameC-DRG-00401
Proprietary NameC-DRG-00402
Animal Common NamesC-DRG-00403
Animal Cell Tissue Fluid BiomoleculeC-DRG-00404
Biotechnology OriginC-DRG-00405
PotencyC-DRG-00501
IndicationsC-DRG-00601
Therapeutic Equivalence CodeC-DRG-00701
Phase 4 Commitment CategoryC-DRG-00901
Phase 4 Fulfillment CategoryC-DRG-00902
Pediatric use Supplement RuleC-DRG-00903
Pediatric Use Supplement Clinical Efficacy Trials CategoryC-DRG-00904
Pediatric Use Supplement PK/PD CategoryC-DRG-00905
Pediatric Use Supplement Safety/Adverse Reaction CategoryC-DRG-00906
Package TypeC-DRG-00907
Pediatric Exclusivity Study TypeC-DRG-00908
Pediatric Exclusivity Study Age GroupC-DRG-00909
Pediatric Exclusivity Study BasisC-DRG-00910
Pediatric Exclusivity Study Drug ListC-DRG-00911
Geriatric Use Supplement RuleC-DRG-00913
Geriatric Use Supplement Clinical Efficacy Trials CategoryC-DRG-00914
Geriatric Use Supplement PK/PD CategoryC-DRG-00915
Geriatric Use Supplement Safety/Adverse Reaction CategoryC-DRG-00916
Industry Meeting TypeC-DRG-00917
Industry Meeting ResponseC-DRG-00918
PACT Commitment CategoryC-DRG-00919
PACT Fulfillment CategoryC-DRG-00920
Global Suplement StatusC-DRG-00921
Plant PartC-DRG-00924
SPL CoatingC-DRG-0925
SPL SymbolC-DRG-0926
SPL ColorC-DRG-0927
SPL SizeC-DRG-0928
SPL ShapeC-DRG-0929
SPL ScoreC-DRG-0930
SPL ImprintC-DRG-0931
SPL ImageC-DRG-0932
SPL DEA ScheduleC-DRG-0933
SPL Flavor C-DRG-0934
Marketing CategoryC-DRG-0935